Paradromics Inc. is a United States-based startup with a mission to build a high data-rate brain computer interface (BCI) to provide technology solutions for people with neurological and brain-related conditions. Founded in 2015 by a team of engineers and neuroscientists, the company received early support from both NIH and DARPA. Its first clinical application aims to help severely motor-impaired individuals communicate, enabling social connection and restoring independence.
The company's slogan, "Building a high data-rate brain computer interface (BCI) to provide technology solutions to unmet medical needs," encapsulates their core objective. The latest milestone for Paradromics was the $50.14M Series A investment on 18 May 2023, which was secured from notable investors including FJ Labs, Dolby Ventures, Green Sand Equity, Prime Movers Lab, 15th Rock, and Westcott LLC.
By leveraging the power of AI and advanced technology, Paradromics aims to pioneer a direct data interface that can potentially restore or enhance brain function. This endeavor reflects the burgeoning intersection of healthcare and technology, offering promising prospects for both medical advancements and investment opportunities.